Next Century Growth Investors LLC Axogen, Inc. Transaction History

Next Century Growth Investors LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2019 May 14, 2019	SELL	$14.62 - $22.13 $5.35 Million - $8.1 Million	-366,057 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$17.09 - $38.25 $4.54 Million - $10.2 Million	265,815 Added 265.17%	366,057 $7.48 Million
Q3 2018 Nov 14, 2018	SELL	$34.05 - $55.9 $3,609 - $5,925	-106 Reduced 0.11%	100,242 $3.69 Million
Q2 2018 Aug 14, 2018	SELL	$36.15 - $52.5 $9.15 Million - $13.3 Million	-253,055 Reduced 71.61%	100,348 $5.04 Million
Q1 2018 May 14, 2018	SELL	$24.4 - $40.25 $7.67 Million - $12.6 Million	-314,239 Reduced 47.07%	353,403 $12.9 Million
Q4 2017 Feb 13, 2018	BUY	$18.5 - $28.6 $201,206 - $311,053	10,876 Added 1.66%	667,642 $18.9 Million
Q3 2017 Nov 14, 2017	BUY	$14.65 - $19.35 $1.88 Million - $2.49 Million	128,488 Added 24.32%	656,766 $12.7 Million
Q2 2017 Aug 14, 2017	BUY	N/A	528,278	528,278 $8.85 Million

163

36.6M

230K

400

Ticker AXGN
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 42,283,700
Market Cap $527M
Description
AxoGen, Inc., together with its subsidiaries, develops and markets surgical solutions for physical damage or transection to peripheral nerves. The company's products include Avance Nerve Graft, a biologically active off-the-shelf processed human nerve allograft for bridging severed nerves without the comorbidities associated with a second surgic...

Get notified when there are updates to the investment portfolio of Next Century Growth Investors LLC, based on Form 13F filings with the SEC.

Stay updated on Next Century Growth Investors LLC with notifications on news.